LA JOLLA PHARMACEUTICAL CO — Form D
LA JOLLA PHARMACEUTICAL CO of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-18. The offering totals $13.6M, of which $5.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-04-18
- Form: D
- Accession: 0001136056-11-000108
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $13.6M
- Amount sold: $5.2M
- Remaining: $8.4M
- Investors: 9
- Date of first sale: 2011-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-158590
Issuer
- Name: LA JOLLA PHARMACEUTICAL CO
- CIK: 0000920465
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2012
- Address: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO, CA, 92122
- Phone: 858-207-4264
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| ROBERT A FILDES | Director | SAN DIEGO, CA |
| DEIRDRE Y GILLESPIE | Director | SAN DIEGO, CA |
| BERTRAND C LIANG | Director | SAN DIEGO, CA |
| STEPHEN M MARTIN | Director | SAN DIEGO, CA |
| DEIRDRE Y GILLESPIE | Executive Officer | SAN DIEGO, CA |
| GAIL A SLOAN | Executive Officer | SAN DIEGO, CA |
| Saiid Zarrabian | Director | San Diego, CA |
| CHESTER ZYGMONT, III | Executive Officer | SAN DIEGO, CA |
| GEORGE TIDMARSH | Director | SAN DIEGO, CA |
| GEORGE TIDMARSH | Executive Officer | SAN DIEGO, CA |
| RUIZ STACEY | Executive Officer | SAN DIEGO, CA |
| JAMES ROLKE | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (1)
More